| 1 |
Han BF, Zheng RS, Zeng HM, et al. Cancer incidence and mortality in China, 2022 [J]. J Natl Cancer Cent, 2024, 4(1): 47-53.
|
| 2 |
中国临床肿瘤学会结直肠癌工作委员会. 中国临床肿瘤学会(CSCO)结直肠癌诊疗指南 2025 [M]. 北京: 人民卫生出版社, 2025.
|
| 3 |
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system [J]. Histopathology, 2020, 76(2):182-188.
|
| 4 |
Gress DM, Edge SB, Greene FL, et al. Principles of Cancer Staging [M]. In: Amin MB, Edge SB, Greene FL, et al. editors. AJCC Cancer Staging Manual, 8th ed. New York: Springer, 2017: 3-30.
|
| 5 |
Cercek A, Lumish M, Sinopoli J, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer [J]. N Engl J Med, 2022, 386(25): 2363-2376.
|
| 6 |
Fokas E, Allgäuer M, Polat B, et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 [J]. J Clin Oncol, 2019, 37(34): 3212-3222.
|
| 7 |
Li J, Qin S, Xu RH, et al. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial [J]. JAMA, 2018, 319(24): 2486-2496.
|
| 8 |
Dasari A, Morris VK, Allegra CJ, et al. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper [J]. Nat Rev Clin Oncol, 2020, 17(12): 757-770.
|
| 9 |
Faber RA, Meijer RP, Droogh DH, et al. Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial [J]. Lancet Gastroenterol Hepatol, 2024, 9(10): 924-934.
|
| 10 |
Pang YZ, Zhao L, Luo ZM, et al. Comparison of 68Ga-FAPI and18F-FDG uptake in gastric, duodenal, and colorectal cancers [J]. Radiology, 2021, 298(2): 393-402.
|